Who makes Biocon's Human Insulin R U-500?

Biocon's Human Insulin R U-500 is developed by Biocon Limited.

What development phase is Biocon's Human Insulin R U-500 in?

Biocon's Human Insulin R U-500 is in Phase 1.

Last reviewed 2026-05-15 · How we verify

Biocon's Human Insulin R U-500

Biocon Limited · Phase 1 active Biologic Quality 0/100

At a glance

Generic name	Biocon's Human Insulin R U-500
Sponsor	Biocon Limited
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Biocon's Human Insulin R U-500 CI brief — competitive landscape report
Biocon's Human Insulin R U-500 updates RSS · CI watch RSS
Biocon Limited portfolio CI